Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Episenta 1000 mg Prolonged-release Granules {equilateral_black_triangle}

Active Ingredient:
sodium valproate
Company:  
Desitin Pharma Ltd See contact details
ATC code: 
N03AG01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Valproate - Poster - Dispensary - Pregnancy Prevention Programme

{healthcare_pro_orange} For Healthcare Professionals

FOR DISPENSARY USE ONLY Pharmacy poster with key information about the Pregnancy Prevention Programme.

{pdf_link}

Valproate - HCP Guide

{healthcare_pro_orange} For Healthcare Professionals

Healthcare Professional (HCP) educational material on important safety information associated with Valproate use.

{pdf_link}

Patient Card - valproate use in female patients

Educational materials for patients on importation safety information card for valproate - Contraception and Pregnancy Prevention

{pdf_link}

Patient Guide - valproate

Patient Guide on important safety information associated with Valproate use - educational material

{pdf_link}

Valproate - Female Annual Risk Acknowledgement Form

THIS INTERACTIVE FORM IS NOT INTENDED FOR HARD COPY USE Interactive form for use with girls and women of childbearing potential taking this product. It is to be completed with their specialist at least once a year to make sure they know and have understood all the risks related to the use of valproate during pregnancy and the need to avoid becoming pregnant while taking valproate.

{pdf_link}

Valproate - White Box Warning Labels

{healthcare_pro_orange} For Healthcare Professionals

FOR DISPENSARY USE ONLY Warning Labels with Valproate Pregnancy Pictogram for Pharmacy to use with white box dispensing of these products.

{pdf_link}

Valproate - Male Annual Risk Acknowledgement Form

THIS INTERACTIVE FORM IS NOT INTENDED FOR HARD COPY USE Interactive form for male patients aged under 55 years to complete with their specialists when starting valproate

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Desitin Pharma Ltd
Company image
Address
Fairbourne Drive , Atterbury , Milton Keynes , Bucks, MK10 9RG, UK
WWW
www.desitin.co.uk
Telephone
+44 (0) 1908 488817
E-mail
[email protected]
Medical Information Direct Line
+44 (0) 1908 488817